Research Topics
| Abdallah G KfourySummaryAffiliation: LDS Hospital Country: USA Publications
| Collaborators
|
Detail Information
Publications
Early screening for antibody-mediated rejection in heart transplant recipientsAbdallah G Kfoury
LDS Hospital and Intermountain Healthcare, Salt Lake City, Utah 84143, USA
J Heart Lung Transplant 26:1264-9. 2007..In this study, we examine whether a pattern of repetitive AMR occurred early enough after transplantation to warrant prospective immunohistochemistry screening in all recently transplanted recipients...
Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patientsAbdallah G Kfoury
Heart Failure Prevention and Treatment Program, Intermountain Medical Center and Intermountain Healthcare, 5121 S Cottonwood Street, Murray, UT 84107, USA
J Card Fail 14:95-102. 2008..Although adherence to these HF care processes may be improving, their collective impact on survival is not yet settled...
A clinical correlation study of severity of antibody-mediated rejection and cardiovascular mortality in heart transplantationAbdallah G Kfoury
Intermountain Medical Center and Intermountain Healthcare, Utah, USA
J Heart Lung Transplant 28:51-7. 2009..In this study, we hypothesized that the severity of AMR, as assessed on EMBs, correlates with cardiovascular mortality in heart transplant recipients...
Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplantMelanie D Everitt
Division of Cardiology, University of Utah, Salt Lake City, Utah, USA
J Heart Lung Transplant 31:686-93. 2012..Yet, compared with adults, the lack of routine surveillance for AMR has limited the growth of evidence in the pediatric population. Herein, we compared outcomes of pediatric HT recipients with and without AMR...
Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?Monica P Revelo
George E Wahlen Veterans Affairs Medical Center, Utah Transplantation Affiliated Hospitals, Salt Lake City, Utah, USA
J Heart Lung Transplant 30:144-50. 2011....
Exceptional mortality prediction by risk scores from common laboratory testsBenjamin D Horne
Cardiovascular Department, Intermountain Medical Center, Murray, Utah 84157, USA
Am J Med 122:550-8. 2009..Many of their components are not commonly used, but they might contain independent risk information. This study tested the ability of a risk score combining all components to predict all-cause mortality...
The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpointsBenjamin D Horne
Cardiovascular Department, Intermountain Medical Center, 5121 S Cottonwood St, Salt Lake City, UT 84107, USA
Eur J Heart Fail 12:1203-13. 2010..Mortality is the most definitive clinical endpoint, but medical care is more easily applied to modify morbidity and thereby prevent death. This study tested whether IMRS is associated with clinical morbidity endpoints...
A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantationAbdallah G Kfoury
Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah, USA
J Heart Lung Transplant 31:46-51. 2012..Debate continues about whether therapeutic intervention is warranted to avoid adverse outcomes. In this study we examine the course of individual episodes of untreated asymptomatic AMR on follow-up endomyocardial biopsy (EMB)...
Superior predictive ability for death of a basic metabolic profile risk scoreHeidi T May
Intermountain Medical Center, Murray, UT 84157, USA
Am Heart J 157:946-54. 2009..Although individual variables are checked for cardiovascular health and risk, combining them into a total BMP-derived score, as to maximize BMP predictive ability, has not been previously attempted...
Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failureStavros G Drakos
Utah Transplantation Affiliated Hospitals U T A H Cardiac Transplant Program, LDS Hospital, and University of Utah School of Medicine, Salt Lake City, Utah 84143, United States
Eur J Heart Fail 9:845-9. 2007....
Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery diseaseHeidi T May
LDS Hospital, Salt Lake City, Utah 84143, USA
Cardiology 107:178-84. 2007..Whether HCY affects development of congestive heart failure (CHF) independent of coronary artery disease (CAD) is uncertain. We evaluated whether increased HCY predicts low ejection fraction or clinical CHF...
Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejectionAbdallah G Kfoury
Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, UT, USA
J Heart Lung Transplant 28:781-4. 2009..In this study, we examined whether a differential impact on cardiovascular mortality (CVM) existed when comparing asymptomatic AMR, to stable MR or CR...
Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and functionFeras M Bader
Division of Cardiology, University of Utah Health Sciences Center, Salt Lake City, UT 84132, USA
Congest Heart Fail 15:63-7. 2009..BNP levels do predict allograft rejection but correlate with allograft function after 6 months following transplant...
Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusionsStavros G Drakos
Utah Transplantation Affiliated Hospitals UTAH Cardiac Transplant Program, Salt Lake City, Utah, USA
J Thorac Cardiovasc Surg 133:1612-9. 2007..We investigated the pattern of sensitization in left ventricular assist device recipients in relation to cellular blood product transfusions received...
Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung TransplantationJose N Nativi
Department of Medicine, Division of Cardiology, University of Utah, Salt Lake City, Utah 84132, USA
J Heart Lung Transplant 30:854-61. 2011..Our aim was to determine the impact of the type of LVAD and implant era on post-transplant survival...
The intermountain risk score predicts incremental age-specific long-term survival and life expectancyBenjamin D Horne
Cardiovascular Department, Intermountain Medical Center, Salt Lake City, Utah, USA
Transl Res 158:307-14. 2011..IMRS may be used to stratify age-specific risk of mortality in research, clinical/preventive, and quality improvement applications. A web calculator is located at http://intermountainhealthcare.org/IMRS...
Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipientsStavros G Drakos
LDS Hospital, University of Utah School of Medicine, Utah Transplantation Affiliated Hospitals Cardiac Transplant Program, Salt Lake City, Utah 84143, USA
Ann Thorac Surg 82:889-93. 2006..0% (3 of 25) of the non-IVIG group (p = 0.5). CONCLUSIONS: The use of low-dose prophylactic IVIG after left ventricular assist device implantation affects neither the incidence nor the severity of HLA allosensitization...
Impact of high-dose inotropic donor support on early myocardial necrosis and outcomes in cardiac transplantationJennifer L Nixon
Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, UT, USA
Clin Transplant 26:322-7. 2012..Our study evaluated whether the use of high-dose inotropic support in potential donors was associated with increased early myocardial necrosis (MN) and worse clinical outcomes after cardiac transplantation...
Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devicesPere A Ventura
Utah Artificial Heart Program, Intermountain Medical Center, Salt Lake City, UT, USA
Clin Transplant 25:E390-5. 2011..In this study, we compared the post-transplant (PTx) outcomes between XVE and HMII using a large national data registry...
Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptideHeidi T May
LDS Hospital, Intermountain Medical Center, Salt Lake City, Utah, USA
Am J Cardiol 100:697-700. 2007..02). In conclusion, the SHFM predicts survival in patients with HF in a hospital-based population, with areas under the curve similar to those from data on which models were initially fit...
Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patternsAbdallah G Kfoury
LDS Hospital, Intermountain Health Care, Salt Lake City, Utah 84143, USA
J Heart Lung Transplant 25:1277-82. 2006..This approach may lead to improved patient and allograft survival...
Risk factors predictive of right ventricular failure after left ventricular assist device implantationStavros G Drakos
Cardiovascular Department, Intermountain Medical Center, Salt Lake City, Utah University of Utah School of Medicine, Salt Lake City, Utah, USA
Am J Cardiol 105:1030-5. 2010....
Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsiesM Elizabeth H Hammond
Department of Pathology, LDS Hospital, Salt Lake City, Utah 84143, USA
J Heart Lung Transplant 24:2015-21. 2005..The aim of this study was to determine whether VASC and ENDO are adequate to act as screening parameters to trigger further AMR investigation...
Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitizationStavros G Drakos
Utah Transplant Affiliated Hospitals UTAH Cardiac Transplant Program, Salt Lake City, UT 84112, USA
J Heart Lung Transplant 28:838-42. 2009..04). Pre-sensitized patients are at higher risk for becoming and remaining highly HLA-allosensitized after LVAD implantation. The HeartMate II LVAD appears to cause less sensitization than HeartMate I...
Allograft rejection in patients supported with continuous-flow left ventricular assist devicesAaron H Healy
UTAH Utah Transplant Affiliated Hospitals Cardiac Transplant Program, University of Utah, Salt Lake City, Utah 84132, USA
Ann Thorac Surg 92:1601-7; discussion 1607. 2011..We sought to analyze the relationship between LVAD flow characteristics and subsequent allograft rejection in bridge to transplant (BTT) patients...
Temporal trends in heart transplantation from high-risk donors: are there lessons to be learned? A multi-institutional analysisJose N Nativi
Department of Cardiology, University of Utah Health Science Center, U T A H Cardiac Transplant Program, Salt Lake City, UT 84132, USA
J Heart Lung Transplant 29:847-52. 2010..After the ODBC, increases in the number of all solid organs transplanted, except for heart, were seen. The aim of this study was to determine if ODBC resulted in temporal changes in the use of hearts from high-risk donors...
Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS)Melanie D Everitt
University of Utah, and Division of Pediatric Cardiology, Primary Children s Medical Center, 100 Mario Capecchi Drive, Salt Lake City, UT 84113, USA
J Heart Lung Transplant 30:395-401. 2011..HF management and approach to orthotopic heart transplant (OHT) may differ from adults without CHD. We sought to compare OHT waitlist characteristics and outcomes for these 2 groups...
Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heartStavros G Drakos
Cardiovascular Department and Utah Artificial Heart Program, Intermountain Medical Center, Salt Lake City, Utah, USA
J Am Coll Cardiol 56:382-91. 2010..This study investigates alterations in myocardial microvasculature, fibrosis, and hypertrophy before and after mechanical unloading of the failing human heart...
Effect of reversible pulmonary hypertension on outcomes after heart transplantationStavros G Drakos
Utah Transplantation Affiliated Hospitals, Cardiac Transplant Program, LDS Hospital, Salt Lake City, Utah 84143, USA
J Heart Lung Transplant 26:319-23. 2007..Conflicting data exist regarding the impact of reversible pulmonary hypertension (PHTN) on post-transplant (Tx) outcomes. In this study we sought to determine the influence of reversible PHTN on outcomes after Tx...
Outcome of noncardiac surgery in patients with ventricular assist devicesJosef Stehlik
VA Salt Lake City Health Care System, Cardiology Division, Salt Lake City, Utah, USA
Am J Cardiol 103:709-12. 2009..In conclusion, outcomes after noncardiac surgery in patients with VADs are favorable, and most patients continue to benefit from the intended purpose of mechanical circulatory support after recovering from noncardiac surgery...
Relation of serum total cholesterol, C-reactive protein levels, and statin therapy to survival in heart failureHeidi T May
LDS Hospital, Salt Lake City, Utah, USA
Am J Cardiol 98:653-8. 2006..In conclusion, elevated TC appears to be associated with improved survival. The effect was stronger in patients receiving statin therapy, but the cause of this differential effect is uncertain...
Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiographyBenjamin D Horne
Cardiovascular Department, Intermountain Medical Center, Murray, Utah, USA
Am J Cardiol 102:814-819. 2008..In conclusion, not only proscription of tobacco, but also routine periodic fasting was associated with lower risk of CAD...
Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for actionStavros G Drakos
UTAH Cardiac Transplant Program, Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA
Curr Opin Cardiol 26:245-55. 2011..Herein, we summarize and integrate insights from studies which investigated how LVAD unloading influences the structure and function of the failing human heart...
Obesity and left ventricular assist device driveline exit site infectionAshley L Raymond
Utah Artificial Heart Program, Intermountain Medical Center, Murray, Utah, USA
ASAIO J 56:57-60. 2010..These results may warrant increased measures to prevent and treat infection in the preimplant and postimplant periods...
Utility of virtual crossmatch in sensitized patients awaiting heart transplantationJosef Stehlik
U T A H Cardiac Transplant Program, University of Utah Hospital, and VA Salt Lake City Health Care System Cardiology Section, 500 Foothill Blvd, Salt Lake City, UT 84148, USA
J Heart Lung Transplant 28:1129-34. 2009..This study examined the accuracy of virtual crossmatch, in which recipient HLA-specific antibodies, identified by solid-phase assays, are compared to the prospective donor HLA-type in heart transplantation...
A novel non-invasive method to assess aortic valve opening in HeartMate II left ventricular assist device patients using a modified Karhunen-Loève transformationCorey J Bishop
Utah Artificial Heart Program, Intermountain Medical Center, Murray, Utah 84157, USA
J Heart Lung Transplant 29:27-31. 2010....
Effect of ABO-incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) databaseMelanie D Everitt
Utah Transplant Affiliated Hospitals U T A H Cardiac Transplant Program, Salt Lake City, Utah, USA
J Heart Lung Transplant 28:1254-60. 2009..ABO-I transplantation has resulted in reduced waitlist mortality in some countries. This study assessed the effect of an ABO-I listing strategy on pre-transplant outcomes in the United States...
Tuberculosis in a solid-organ transplant recipient: modern-day implicationsAyad Jazrawi
UTAH Cardiac Transplant Program, Salt Lake City, Utah, USA
J Heart Lung Transplant 28:191-3. 2009..Herein we examine the role of the different tests used in diagnosis of TB and review the specifics of anti-mycobacterial therapy and the public health implications of TB in a SOT recipient...
Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory supportStavros G Drakos
LDS Hospital, Salt Lake City, Utah 84143, USA
Ann Thorac Surg 83:62-7. 2007..Determining which pretransplantation (TX) characteristics predict the development of chronic renal dysfunction (CRD) or death after heart TX would enable more accurate risk assessment at the time of candidate evaluation...
Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantationJose N Nativi
U T A H Cardiac Transplant Program, Salt Lake City, Utah, USA
J Heart Lung Transplant 29:235-9. 2010..As such, organs would be allocated to the sickest recipients with highest listing status across the region. Our aim was to determine the impact of the new policy on the procurement and transplant process within our program...
Effect of mechanical circulatory support on outcomes after heart transplantationStavros G Drakos
Utah Transplantation Affiliate Hospitals Cardiac Transplant Program, Salt Lake City, UT, USA
J Heart Lung Transplant 25:22-8. 2006..The incidence of chronic renal insufficiency was actually lower in the MCS Group (15.3% vs 37.9%, p = .001). CONCLUSION: Post-transplant outcomes after pre-transplant use of MCS are similar to those when MCS is not required...
Improving outcomes with long-term "destination" therapy using left ventricular assist devicesJames W Long
Utah Artificial Heart Program, LDS Hospital, Salt Lake City, Utah 84143, USA
J Thorac Cardiovasc Surg 135:1353-60; discussion 1360-1. 2008....
Controversies in defining cardiac antibody-mediated rejection: need for updated criteriaAbdallah G Kfoury
Intermountain Medical Center and Intermountain Healthcare, Cardiac Transplant Program, Salt Lake City, Utah 84107, USA
J Heart Lung Transplant 29:389-94. 2010..This perspective examines some of the contentious and unresolved issues in cardiac AMR as the transplant community makes concrete steps towards updating its defining criteria...
Percutaneous coronary interventions with stents in cardiac transplant recipientsFeras M Bader
Department of Cardiology, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA
J Heart Lung Transplant 25:298-301. 2006..The aim of this study was to review our experience with percutaneous coronary intervention (PCI) with stents in cardiac transplant recipients...
Noninvasive predictor of HeartMate XVE pump failure by neural network and waveform analysisNathanael O Mason
Utah Artificial Heart Program, Intermountain Medical Center part of Intermountain Healthcare, Murray, Utah, USA
ASAIO J 56:1-5. 2010..Waveforms (n = 454) were collected for 21 patients with failed pumps. An artificial neural network was used to predict pump failure within 30 days from the waveform characteristics identified though signal processing...
End-of-life decision making and implementation in recipients of a destination left ventricular assist deviceSally Brush
Utah Artificial Heart Program, and Intermountain Medical Center and Intermountain Healthcare, Salt Lake City, Utah 84107, USA
J Heart Lung Transplant 29:1337-41. 2010..Nonetheless, end-of-life (EOL) issues are inevitable and how to approach them underreported...
Tricuspid valve replacement after cardiac transplantationRami Alharethi
Cardiology Division, University of Utah Health Sciences Center, Salt Lake City, USA
J Heart Lung Transplant 25:48-52. 2006..Flail leaflets are the most common operative finding, suggesting that biopsy-induced trauma is the likely cause of severe TI in these patients...
C-reactive protein predicts death in patients with non-ischemic cardiomyopathyBrianna S Ronnow
Cardiovascular Department, LDS Hospital, Salt Lake City, Utah 84143, USA
Cardiology 104:196-201. 2005..0) significantly and independently predicted mortality. Even in the absence of coronary artery disease, patients with left ventricular dysfunction are at increased risk of mortality based on their baseline CRP concentrations...
Molecular testing for long-term rejection surveillance in heart transplant recipients: design of the Invasive Monitoring Attenuation Through Gene Expression (IMAGE) trialMichael X Pham
Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, California 94305, USA
J Heart Lung Transplant 26:808-14. 2007....
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selectionKatherine Lietz
Cardiovascular Division, University of Minnesota, Minneapolis, USA
Circulation 116:497-505. 2007..In the present study, we describe outcomes of DT in the post-REMATCH era in the United States...
